PLoS ONE · 2014 · 80 citations · 31 references
MedicineMolecular MedicineNephrologyGene ExpressionRenal PathophysiologyTranscriptomicsAcute Kidney InjuryImmunosuppression In Kidney TransplantationMicrorna BiologyRenal DiseaseTransplant BiomarkersTransplant RejectionAllograft Biopsy DiagnosisCirculating MicrornasDifferential Transcript ExpressionFalse Discovery RateFalse Discovery Rate ControlMessenger Rna (Mrna) ProfilingRenal Biomarker DiscoveryTranscript-level Expression Analysis
Acute kidney injury (AKI) affects roughly 25% of all recipients of deceased donor organs. The prevention of post-transplant AKI is still an unmet clinical need. We prospectively collected zero-hour, indication as well as protocol kidney biopsies from 166 allografts between 2011 and 2013. In this cohort eight cases with AKI and ten matched allografts without pathology serving as control group were identified with a follow-up biopsy within the first twelve days after engraftment. For this set the zero-hour and follow-up biopsies were subjected to genome wide microRNA and mRNA profiling and analysis, followed by validation in independent expression profiles of 42 AKI and 21 protocol biopsies for strictly controlling the false discovery rate. Follow-up biopsies of AKI allografts compared to time-matched protocol biopsies, further baseline adjustment for zero-hour biopsy expression level and validation in independent datasets, revealed a molecular AKI signature holding 20 mRNAs and two miRNAs (miR-182-5p and miR-21-3p). Next to several established biomarkers such as lipocalin-2 also novel candidates of interest were identified in the signature. In further experimental evaluation the elevated transcript expression level of the secretory leukocyte peptidase inhibitor (SLPI) in AKI allografts was confirmed in plasma and urine on the protein level (p<0.001 and p = 0.003, respectively). miR-182-5p was identified as a molecular regulator of post-transplant AKI, strongly correlated with global gene expression changes during AKI. In summary, we identified an AKI-specific molecular signature providing the ground for novel biomarkers and target candidates such as SLPI and miR-182-5p in addressing AKI.
31
In silico prediction of protein-protein interactions in human macrophages
Oussema Souiai, Fatma Z. Guerfali, Slimane Ben Miled et al. · BMC Research Notes · 2014 · 11K citations · Full text
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Cellular Signalling · 2007 · 4.8K citations
MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing
Andrew Grimson, Kyle Kai‐How Farh, Wendy K. Johnston et al. · Molecular Cell · 2007 · 3.8K citations · Full text